10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
GILEAD SCIENCES, INC. | ||
Ticker: GILD Fiscal Year: 2013 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2013 10-K (Filed: Feb 25, 2014) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2013 | Dec 31, 2012 | |
| Assets [Abstract] | ||
| Assets, Current [Abstract] | ||
| Cash and cash equivalents | $ 2,112,806 | 1,803,694 |
| Short-term marketable securities | 18,756 | 58,556 |
| Accounts receivable, net of allowances of $334,307 at December 31, 2013 and $261,013 at December 31, 2012 | 2,100,286 | 1,751,388 |
| Inventories | 2,055,788 | 1,744,982 |
| Deferred tax assets | 330,530 | 262,641 |
| Prepaid taxes | 398,010 | 348,420 |
| Prepaid expenses | 165,652 | 102,364 |
| Other current assets | 91,925 | 84,302 |
| Total current assets | 7,273,753 | 6,156,347 |
| Assets, Noncurrent [Abstract] | ||
| Property, plant and equipment, net | 1,166,181 | 1,100,259 |
| Long-term portion of prepaid royalties | 198,766 | 175,790 |
| Long-term deferred tax assets | 154,765 | 131,107 |
| Long-term marketable securities | 439,028 | 719,836 |
| Intangible assets, net | 11,900,106 | 11,736,393 |
| Goodwill | 1,169,023 | 1,060,919 |
| Other long-term assets | 195,163 | 159,187 |
| Total assets | 22,496,785 | 21,239,838 |
| Liabilities and Stockholders' Equity [Abstract] | ||
| Current liabilities [Abstract] | ||
| Accounts payable | 1,255,914 | 1,327,339 |
| Accrued government rebates | 983,490 | 745,148 |
| Accrued compensation and employee benefits | 243,540 | 204,593 |
| Income taxes payable | 10,855 | 13,403 |
| Other accrued liabilities | 1,023,938 | 674,762 |
| Deferred revenues | 110,640 | 103,162 |
| Current portion of long-term debt and other obligations, net | 2,697,044 | 1,169,490 |
| Total current liabilities | 6,325,421 | 4,237,897 |
| Liabilities, Noncurrent [Abstract] | ||
| Long-term deferred revenues | 21,979 | 20,532 |
| Long-term Debt, net | 3,938,708 | 7,054,555 |
| Long-term income taxes payable | 162,412 | 115,822 |
| Long-term deferred tax liabilities | 83,286 | 10,190 |
| Other long-term obligations | 156,647 | 249,973 |
| Commitments and contingencies (Note 11) | ||
| Temporary Equity [Abstract] | ||
| Equity component of currently redeemable convertible notes (Note 10) | 63,831 | 7,147 |
| Stockholders' Equity [Abstract] | ||
| Preferred stock, par value $0.001 per share; 5,000 shares authorized; none outstanding | 0 | 0 |
| Common stock, par value $0.001 per share; shares authorized of 5,600,000 at December 31, 2013 and 2,800,000 at December 31, 2012; shares issued and outstanding of 1,534,414 at December 31, 2013 and 1,519,163 at December 31, 2012 (1) | 1,534 [1] | 1,519 |
| Additional paid-in capital | 5,386,735 | 5,641,944 |
| Accumulated other comprehensive loss | (124,446) | (45,615) |
| Retained earnings | 6,105,244 | 3,704,744 |
| Total Gilead stockholders equity | 11,369,067 | 9,302,592 |
| Noncontrolling interest | 375,434 | 241,130 |
| Total stockholders equity | 11,744,501 | 9,543,722 |
| Total liabilities and stockholders equity | 22,496,785 | 21,239,838 |
| [1] The common stock shares and additional paid-in capital for all periods presented reflect the two-for-one stock split in the form of a stock dividend which took effect on January 25, 2013. | ||
| External Links | |
| GILEAD SCIENCES, INC. (GILD) Fiscal Year 2013 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |